Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

OrbusNeich Medical Group Holdings Limited (6929) Price & Analysis

6929 Stock Chart & Stats

HK$3.74-HK$0.06(-1.58%)
At close: 4:00 PM EDT
HKD 3.75HKD 43 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
HKD 3.66 - HKD 3.74
52-Week Range
HKD 3.45 - HKD 4.87
Previous Close
HKD 3.80
Volume
48.00K
Average Volume (3M)
41.83K
Market Cap
HKD 3.08B
Enterprise Value
HKD 1.72B
Total Cash (Recent Filing)
HKD 199.23M
Total Debt (Recent Filing)
HKD 6.77M
Price to Earnings (P/E)
8.9
Beta
0.38
Next Earnings
Mar 11, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
5.35%

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth

Sustained revenue expansion indicates continued demand for the company’s interventional cardiology and endovascular products. Growth across several years provides a durable base for operating leverage, product adoption and broader international commercialization.

Strong Gross Margins

Consistently high gross margins support the economics of the device portfolio and provide resilience against manufacturing, distribution and research costs. This profitability cushion can help fund innovation and market expansion over the medium term.

Conservative Balance Sheet

Very low leverage materially reduces financial risk and interest burdens, preserving flexibility to invest in product development, manufacturing capacity and international distribution. The large equity base also strengthens resilience through changing industry conditions.

Bears Say

Weak Cash Conversion

Weak conversion of accounting earnings into operating cash may indicate working-capital or reinvestment pressure. If sustained, it could constrain internally funded growth and reduce the company’s ability to convert strong reported margins into financial flexibility.

Very Low Free Cash Flow

Persistently subdued free cash flow reduces the cash available for product development, acquisitions, dividends or balance-sheet strengthening. The recent decline suggests that investment needs or working-capital requirements are absorbing a larger share of operating resources.

Margin Compression

Margin deterioration despite continued sales growth indicates that incremental revenue is currently less profitable than before. If this persists, it could limit earnings growth, weaken returns on capital and reduce the benefits of the company’s strong gross-margin profile.

OrbusNeich Medical Group Holdings Limited News

6929 FAQ

What was OrbusNeich Medical Group Holdings Limited’s price range in the past 12 months?
OrbusNeich Medical Group Holdings Limited lowest stock price was HK$3.45 and its highest was HK$4.87 in the past 12 months.
What is OrbusNeich Medical Group Holdings Limited’s market cap?
OrbusNeich Medical Group Holdings Limited’s market cap is HK$3.08B.
When is OrbusNeich Medical Group Holdings Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OrbusNeich Medical Group Holdings Limited’s earnings last quarter?
OrbusNeich Medical Group Holdings Limited released its earnings results on Aug 13, 2026. The company reported HK$0.204 earnings per share for the quarter.
Is OrbusNeich Medical Group Holdings Limited overvalued?
According to Wall Street analysts OrbusNeich Medical Group Holdings Limited’s price is currently Undervalued.
Does OrbusNeich Medical Group Holdings Limited pay dividends?
OrbusNeich Medical Group Holdings Limited pays a Notavailable dividend of HK$0.08 which represents an annual dividend yield of 5.35%. See more information on OrbusNeich Medical Group Holdings Limited dividends here
What is OrbusNeich Medical Group Holdings Limited’s EPS estimate?
OrbusNeich Medical Group Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrbusNeich Medical Group Holdings Limited have?
OrbusNeich Medical Group Holdings Limited has 827,968,300 shares outstanding.
What happened to OrbusNeich Medical Group Holdings Limited’s price movement after its last earnings report?
OrbusNeich Medical Group Holdings Limited reported an EPS of HK$0.204 in its last earnings report. Following the earnings report the stock price went up 0.377%.
Which hedge fund is a major shareholder of OrbusNeich Medical Group Holdings Limited?
Currently, no hedge funds are holding shares in HK:6929
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology